ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/07 | 1,636 | 1,644 | 1,624 | 1,632 | -2 | -0.1% | 39,300 |
| 2024/11/06 | 1,636 | 1,644 | 1,621 | 1,634 | -1 | -0.1% | 45,300 |
| 2024/11/05 | 1,645 | 1,654 | 1,635 | 1,635 | -10 | -0.6% | 27,600 |
| 2024/11/01 | 1,650 | 1,660 | 1,642 | 1,645 | -18 | -1.1% | 28,200 |
| 2024/10/31 | 1,649 | 1,663 | 1,643 | 1,663 | +14 | +0.8% | 21,000 |
| 2024/10/30 | 1,634 | 1,651 | 1,631 | 1,649 | +10 | +0.6% | 42,400 |
| 2024/10/29 | 1,619 | 1,644 | 1,614 | 1,639 | +20 | +1.2% | 31,600 |
| 2024/10/28 | 1,637 | 1,637 | 1,602 | 1,619 | +22 | +1.4% | 22,000 |
| 2024/10/25 | 1,636 | 1,636 | 1,592 | 1,597 | -39 | -2.4% | 54,700 |
| 2024/10/24 | 1,623 | 1,636 | 1,617 | 1,636 | +13 | +0.8% | 14,600 |
| 2024/10/23 | 1,635 | 1,637 | 1,619 | 1,623 | -12 | -0.7% | 31,300 |
| 2024/10/22 | 1,671 | 1,671 | 1,630 | 1,635 | -27 | -1.6% | 36,400 |
| 2024/10/21 | 1,665 | 1,670 | 1,657 | 1,662 | -10 | -0.6% | 28,500 |
| 2024/10/18 | 1,679 | 1,682 | 1,666 | 1,672 | -5 | -0.3% | 24,000 |
| 2024/10/17 | 1,686 | 1,686 | 1,671 | 1,677 | -2 | -0.1% | 16,800 |
| 2024/10/16 | 1,662 | 1,693 | 1,662 | 1,679 | +18 | +1.1% | 39,800 |
| 2024/10/15 | 1,653 | 1,670 | 1,653 | 1,661 | +7 | +0.4% | 20,200 |
| 2024/10/11 | 1,661 | 1,670 | 1,654 | 1,654 | -10 | -0.6% | 14,900 |
| 2024/10/10 | 1,672 | 1,672 | 1,651 | 1,664 | -8 | -0.5% | 18,300 |
| 2024/10/09 | 1,673 | 1,673 | 1,661 | 1,672 | +6 | +0.4% | 24,100 |
| 2024/10/08 | 1,675 | 1,677 | 1,662 | 1,666 | -14 | -0.8% | 19,500 |
| 2024/10/07 | 1,693 | 1,693 | 1,677 | 1,680 | +1 | +0.1% | 48,500 |
| 2024/10/04 | 1,650 | 1,685 | 1,650 | 1,679 | +31 | +1.9% | 72,100 |
| 2024/10/03 | 1,639 | 1,648 | 1,631 | 1,648 | +32 | +2% | 35,600 |
| 2024/10/02 | 1,630 | 1,632 | 1,615 | 1,616 | -16 | -1% | 53,500 |
| 2024/10/01 | 1,622 | 1,634 | 1,613 | 1,632 | +10 | +0.6% | 30,000 |
| 2024/09/30 | 1,586 | 1,628 | 1,586 | 1,622 | +5 | +0.3% | 43,000 |
| 2024/09/27 | 1,595 | 1,636 | 1,595 | 1,617 | +27 | +1.7% | 69,400 |
| 2024/09/26 | 1,570 | 1,596 | 1,562 | 1,590 | +30 | +1.9% | 53,900 |
| 2024/09/25 | 1,588 | 1,588 | 1,560 | 1,560 | -10 | -0.6% | 37,800 |
| 2024/09/24 | 1,570 | 1,582 | 1,562 | 1,570 | ±0 | ±0% | 32,900 |
| 2024/09/20 | 1,565 | 1,581 | 1,562 | 1,570 | +13 | +0.8% | 39,300 |
| 2024/09/19 | 1,564 | 1,579 | 1,557 | 1,557 | ±0 | ±0% | 41,700 |
| 2024/09/18 | 1,566 | 1,573 | 1,550 | 1,557 | -10 | -0.6% | 17,100 |
| 2024/09/17 | 1,555 | 1,573 | 1,549 | 1,567 | +12 | +0.8% | 45,200 |
| 2024/09/13 | 1,597 | 1,597 | 1,555 | 1,555 | -29 | -1.8% | 29,700 |
| 2024/09/12 | 1,599 | 1,599 | 1,576 | 1,584 | +14 | +0.9% | 20,900 |
| 2024/09/11 | 1,608 | 1,623 | 1,556 | 1,570 | -36 | -2.2% | 54,400 |
| 2024/09/10 | 1,636 | 1,642 | 1,606 | 1,606 | -15 | -0.9% | 25,600 |
| 2024/09/09 | 1,579 | 1,631 | 1,579 | 1,621 | +3 | +0.2% | 37,900 |
| 2024/09/06 | 1,638 | 1,642 | 1,605 | 1,618 | -20 | -1.2% | 42,500 |
| 2024/09/05 | 1,580 | 1,669 | 1,575 | 1,638 | +57 | +3.6% | 123,800 |
| 2024/09/04 | 1,585 | 1,601 | 1,577 | 1,581 | -21 | -1.3% | 72,000 |
| 2024/09/03 | 1,590 | 1,605 | 1,586 | 1,602 | +8 | +0.5% | 44,000 |
| 2024/09/02 | 1,615 | 1,615 | 1,588 | 1,594 | -4 | -0.3% | 25,600 |
| 2024/08/30 | 1,602 | 1,609 | 1,595 | 1,598 | -5 | -0.3% | 34,400 |
| 2024/08/29 | 1,585 | 1,603 | 1,581 | 1,603 | +3 | +0.2% | 28,700 |
| 2024/08/28 | 1,600 | 1,602 | 1,585 | 1,600 | ±0 | ±0% | 40,700 |
| 2024/08/27 | 1,598 | 1,610 | 1,585 | 1,600 | +3 | +0.2% | 48,300 |
| 2024/08/26 | 1,626 | 1,626 | 1,579 | 1,597 | -20 | -1.2% | 77,000 |
101～
150
件表示中 / 2272件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 139,500円 | +1.2% | -13.9% | 6.09% | 8.22倍 | 1.54倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ダイト | 206,700円 | +4.5% | -10.8% | 3.39% | 13.58倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| 富士製薬 | 123,800円 | +15.7% | +5.3% | 3.68% | 8.95倍 | 0.66倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| ヘリオス | 21,700円 | +150.0% | - | 0.00% | - | 10.65倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| 扶桑薬 | 211,000円 | +8.3% | +98.1% | 3.89% | 6.94倍 | 0.47倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム
